ENLV News
Enlivex Therapeutics Ltd.
$1.25
-$0.01(-1.19%)
37
Overall
80
Value
9
Tech
23
Quality
Market Cap
$1.93M
Volume
20.70K
52W Range
$1.22 - $434.40
Target Price
$1,280.00
ENLV news: the latest Enlivex Therapeutics Ltd. headlines, press releases and market updates, newest first.
Latest ENLV News
- Enlivex Reports Durable 12-Month Allocetra Data in Knee Osteoarthritis TrialTipRanks Auto-Generated Newsdesk · Nov 2, 2026
- Enlivex to Implement 1-for-16 Reverse Share Split Effective October 27, 2026TipRanks Auto-Generated Newsdesk · Oct 22, 2026
- Enlivex Slashes Costs and Workforce to Prioritize Phase 2b Knee Osteoarthritis TrialTipRanks Auto-Generated Newsdesk · Oct 19, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENLV | $1.25 | -1.2% | 20.70K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW